Sei Investments CO Ascendis Pharma A/S Transaction History
Sei Investments CO
- $75.3 Billion
- Q4 2024
A detailed history of Sei Investments CO transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Sei Investments CO holds 263,582 shares of ASND stock, worth $31.5 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
263,582
Previous 273,747
3.71%
Holding current value
$31.5 Million
Previous $40.9 Million
11.24%
% of portfolio
0.05%
Previous 0.05%
Shares
25 transactions
Others Institutions Holding ASND
# of Institutions
238Shares Held
58.7MCall Options Held
205KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.16 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$661 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$596 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$527 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$500 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $6.67B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...